Cross infection control measures and the treatment of patients at risk of Creutzfeldt Jakob Disease in UK general dental practice

British Dental Journal

Volumn 191, Issue 2, 2001, Pages 87-90

  Bagg, J ^a   Sweeney, C P ^a   Roy, K M ^a   Sharp, T ^a   Smith, A ^a  

^a GLASGOW DENTAL HOSPITAL AND SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANAMNESIS; ARTICLE; CLINICAL PRACTICE; CREUTZFELDT JAKOB DISEASE; DENTAL CARE; DISEASE TRANSMISSION; DISINFECTION; FEMALE; GENERAL PRACTICE; HUMAN; INFECTION CONTROL; INSTRUMENT STERILIZATION; INSTRUMENTATION; MALE; METHODOLOGY; MIDDLE AGED; PATIENT REFERRAL; QUESTIONNAIRE; UNITED KINGDOM;

ADULT; CREUTZFELDT-JAKOB SYNDROME; DENTAL CARE FOR CHRONICALLY ILL; DENTIST'S PRACTICE PATTERNS; DISINFECTION; FEMALE; GENERAL PRACTICE, DENTAL; GREAT BRITAIN; HUMANS; INFECTION CONTROL, DENTAL; MALE; MEDICAL HISTORY TAKING; MIDDLE AGED; QUESTIONNAIRES; REFERRAL AND CONSULTATION; STERILIZATION;

EID: 0035964083     PISSN: 00070610     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bdj.4801104a     Document Type: Article

References (19)

1. Johnson R T, Gibbs C J. Medical progress: Creutzfeldt-Jakob Disease and related transmissible spongiform encephalopathies. N Engl J Med 1998; 339: 1994-2004.
2. Will R G, Ironside J W, Zeidler M et al. A new variant of Creutzfeldt-Jakob Disease in the UK. Lancet 1996; 347: 921-925.
3. Hill A F, Desbruslais M, Joiner S, Sidle K C L, Gowland I, Collinge J. The same prion strain causes vCJD and BSE. Nature 1997; 389: 448-450.
4. Bruce M E, Will R G, Ironside J W et al. Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent. Nature 1997; 389: 498-501.
5. Taylor D M. Inactivation of prions by physical and chemical means. J Hosp Inject 1999; 43 (suppl): S69-S76.
6. Will R G, Matthews W B. Evidence for case-to-case transmission of Creutzfeldt-Jakob disease. J Neurol Neurosurg Psych 1982; 45: 235-238.
7. Collins S, Law M G, Fletcher A, Boyd A, Kaldor J, Masters C L. Surgical treatment and risk of sporadic Creutzfeldt-Jakob disease: a case-control study. Lancet 1999; 353: 693-697.
8. Adams D H, Edgar W M. Transmission of agent of Creutzfeldt-Jakob disease. Br Med J 1978; 1: 987.
9. Carp R I. Transmission of scrapie by oral route: effect of gingival scarification. Lancet 1982; 16: 170-171.
10. Ingrosso L, Pisani F, Pocchiari M. Transmission of the 263K scrapie strain by the dental route. J Gen Virol 1999; 80: 3043-3047.
11. Davanipour Z, Alter M, Sobel E, Asher D M, Gajdusek D C. Creutzfeldt-Jakob disease: possible medical risk factors. Neurol 1985; 35: 1483-1486
12. Van Duijn C M, Delasnerie-Laupretre N, Masullo C, Zerr I, de Silva R, Wientjens D P W M et al. Case-control study of risk factors of Creutzfeldt-Jakob disease in Europe during 1993-95. Lancet 1998; 351: 1081-1085.
13. Arakawa K, Nagara H, Itoyama Y, Doh-ura K, Tomokane N, Tateishi J, Goto I. Clustering of three cases of Creutzfeldt-Jakob disease near Fukuoka City, Japan. Acta Neurol Scand 1991; 84: 445-447.
14. Blanquet-Gossard F, Sazdovitch V, Jean A, Deslys J-P, Dormont D, Hauw J-J et al. Prion protein is not detectable in dental pulp from patients with Creutzfeldt-Jakob disease. J Dent Res 2000; 79: 700.
15. Hill A F, Butterworth R J, Joiner S et al. Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsies. Lancet 1999; 353: 83-89.
16. British Dental Association. Fact File: Creutzfeldt-Jakob Disease. August 2000.
17. Dobson R. First results of vCJD survey show no signs of prion. Br Med J 2000; 320: 1226
18. Ashraf H. Early results of study into vCJD epidemic inconclusive. Lancet 2000; 355: 1619-1626.
19. Laurenson I F, Whyte A S, Fox C, Babb J R. Contaminated surgical instruments and variant Creutzfeldt-Jakob disease. Lancet 1999; 354: 1823-1826.